bpc-157 human clinical trials randomized The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity If BPC-157 worked as well
Description
The reconstitution process itself is straightforward, but accuracy matters
Consequences include suspensions and potential lifetime bans for repeated violations
This injection can be taken up to twice each week
This testing protocol confirms peptide sequence, concentration and absence of contaminants that could affect experimental results
As with any investigational substance, unknown or idiosyncratic responses cannot be excluded, and the long-term safety of BPC-157 has not been formally characterised
